dairy and semaglutide on GLP-1 Therapy: Tolerance & Biomarkers – PlexusDx 5 Best Foods While on
Description
The FDA-approved injection sites include the abdomen, thigh, and upper arm
If you have any of those, the risk calculation changes significantly
Many people experience mild gastrointestinal symptoms during dose escalation, which often improve as the body adjusts to treatment
These included Mounjaro, Trulicity, Wegovy, and Saxenda
Saxenda is not indicated as a lipid-lowering agent in the manner of statins or fibrates
It can be hypothesized that insufficient insurance coverage and high out of pocket costs may leave people taking GLP-1 agonists with fewer financial resources for other expenses
